Novartis AG
Aminopyridine derivatives and their use as selective ALK-2 inhibitors

Abstract:

The invention relates to a compound of formula (I) in free form or in pharmaceutically acceptable salt form ##STR00001## to pharmaceutical compositions comprising said compound and to the use of said compound in the treatment of heterotopic ossification and fibrodysplasia ossificans progressiva.